Press Resease

Albumin Market - Global Industry Analysis

Albumin Market by Product (Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin), by Application (Therapeutics & Diagnostics, Drug Delivery, Vaccine Ingredient, Culture Medium Ingredient & Stabilizer, In-vitro Fertilization, and Others), and by End-User (Pharmaceutical & Biotechnology Industry, Research Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Published Date: 17-Oct-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3434 Status : Published

Global albumin market expected to generate around USD 5.87 billion in revenue by the end of 2024, growing at a CAGR of around 6.0% between 2018 and 2024. Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively.

Description

The report covers forecast and analysis for the albumin market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the albumin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the albumin market on a global level.

In order to give the users of this report a comprehensive view of the albumin market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Albumin Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type, and regional expansion of major participants involved in the market.

The study provides a decisive view of the albumin market by segmenting it on the product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demands for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorization into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for albumin market based on all segments in all the regions and countries.

The main players in the global albumin market are Behring LLC, HiMedia Laboratories Pvt. Ltd., Albumedix A/S, Grifols International S.A., Albumin Therapeutics, LLC, InVitria, RayBiotech, Inc., Octapharma AG, Sigma-Aldrich Co., and SeraCare Life Sciences.

This report segments the global albumin market as follows:

Global Albumin Market: Product Segment Analysis

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin

Global Albumin Market: Application Segment Analysis

  • Therapeutics and Diagnostics
  • Drug Delivery
  • Vaccine Ingredient
  • Culture Medium Ingredient & Stabilizer
  • In-vitro Fertilization
  • Others

Global Albumin Market: End-User Segment Analysis

  • Pharmaceutical & Biotechnology Industry
  • Research Institutes
  • Others

Global Albumin Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global albumin market, 2015 - 2024 (USD Billion)
    • 2.2. Global albumin market: Snapshot
  •  
  • Chapter 3. Albumin Market: Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global albumin market drivers: Impact analysis
      • 3.2.2. Increase in use of albumin for R&D
      • 3.2.3. Rising production of immunoglobulin
      • 3.2.4. Technological Development
      • 3.2.5. Increasing use of albumin as an excipient
    • 3.3. Market Restraints
      • 3.3.1. Global albumin market restraints: Impact analysis
      • 3.3.2. Stringent regulations
      • 3.3.3. High Cost
      • 3.3.4. Expertise required to set up production plants
    • 3.4. Opportunities
      • 3.4.1. Emerging markets
      • 3.4.2. Expanding applications of Albumin
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by application segment
      • 3.6.3. Market attractiveness analysis, by end user segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Albumin Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global albumin market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New material launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Albumin Market -Product Segment Analysis
    • 5.1. Global albumin market: Product overview
      • 5.1.1. Global albumin market revenue share, by product, 2017 and 2024
    • 5.2. Human Serum Albumin
      • 5.2.1. Global albumin market for human serum albumin, 2015 - 2024 (USD Billion)
    • 5.3. Bovine Serum Albumin
      • 5.3.1. Global albumin market for bovine serum albumin, 2015 - 2024 (USD Billion)
    • 5.4. Recombinant Albumin
      • 5.4.1. Global albumin market for recombinant albumin, 2015 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Albumin Market - Application Segment Analysis
    • 6.1. Global albumin market: Application overview
      • 6.1.1. Global albumin market revenue share, by application, 2017 and 2024
    • 6.2. Drug Delivery
      • 6.2.1. Global albumin market for drug delivery, 2015 - 2024 (USD Billion)
    • 6.3. Vaccine Ingredient
      • 6.3.1. Global albumin market for vaccine ingredient, 2015 - 2024 (USD Billion)
    • 6.4. Culture Medium Ingredient & Stabilizer
      • 6.4.1. Global albumin market for culture medium ingredient & stabilizer, 2015 - 2024 (USD Billion)
    • 6.5. In-vitro Fertilization
      • 6.5.1. Global albumin market for in-vitro fertilization, 2015 - 2024 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global albumin market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Albumin Market - End-User Segment Analysis
    • 7.1. Global albumin market: Type of molecule overview
      • 7.1.1. Global albumin market revenue share, by end-user, 2017 and 2024
    • 7.2. Pharmaceutical & Biotechnology Industry
      • 7.2.1. Global albumin market for pharmaceutical & biotechnology industry, 2015 - 2024 (USD Billion)
    • 7.3. Research Institutes
      • 7.3.1. Global albumin market for research institutes, 2015 - 2024 (USD Billion)
    • 7.4. Others
      • 7.4.1. Global albumin market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 8. Global Albumin Market - Regional Segment Analysis
    • 8.1. Global albumin market: Regional overview
      • 8.1.1. Global albumin market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America albumin market, 2015 - 2024 (USD Billion)
      • 8.2.2. North America albumin market revenue, by product, 2015 - 2024 (USD Billion)
      • 8.2.3. North America albumin market revenue, by application, 2015 - 2024 (USD Billion)
      • 8.2.4. North America albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.2.5.2. The U.S. albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.2.5.3. The U.S. albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.2.6. Canada
        • 8.2.6.1. Canada albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.2.6.2. Canada albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.2.6.3. Canada albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe albumin market, 2015 - 2024 (USD Billion)
      • 8.3.2. Europe albumin market revenue, by product, 2015 - 2024 (USD Billion)
      • 8.3.3. Europe albumin market revenue, by application, 2015 - 2024 (USD Billion)
      • 8.3.4. Europe albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.3.5.2. UK albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.3.5.3. UK albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.3.6. Germany
        • 8.3.6.1. Germany albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.3.6.2. Germany albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.3.6.3. Germany albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.3.7.2. France albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.3.7.3. France albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.3.8.2. Rest of Europe albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.3.8.3. Rest of Europe albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific albumin market, 2015 - 2024 (USD Billion)
      • 8.4.2. Asia Pacific albumin market revenue, by product, 2015 - 2024 (USD Billion)
      • 8.4.3. Asia Pacific albumin market revenue, by application, 2015 - 2024 (USD Billion)
      • 8.4.4. Asia Pacific albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.4.5.2. China albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.4.5.3. China albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.4.6.2. Japan albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.4.6.3. Japan albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.4.7.2. India albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.4.7.3. India albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America albumin market, 2015 - 2024 (USD Billion)
      • 8.5.2. Latin America albumin market revenue, by product, 2015 - 2024 (USD Billion)
      • 8.5.3. Latin America albumin market revenue, by application, 2015 - 2024 (USD Billion)
      • 8.5.4. Latin America albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.5.5.2. Brazil albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.5.5.3. Brazil albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America albumin market revenue, by product, 2015 - 2024 (USD Billion)
        • 8.5.6.2. Rest of Latin America albumin market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.5.6.3. Rest of Latin America albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa albumin market, 2015 - 2024 (USD Billion)
      • 8.6.2. The Middle East and Africa albumin market revenue, by product, 2015 - 2024 (USD Billion)
      • 8.6.3. The Middle East and Africa albumin market revenue, by application, 2015 - 2024 (USD Billion)
      • 8.6.4. The Middle East and Africa albumin market revenue, by end-user, 2015 - 2024 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Behring LLC
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. HiMedia Laboratories Pvt. Ltd.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Albumedix A/S
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Grifols International S.A.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Albumin Therapeutics, LLC
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. InVitria
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Octapharma AG
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. RayBiotech, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Sigma-Aldrich Co.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. SeraCare Life Sciences
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments 

List of Figures

1. Market research process
2. Market research methodology
3. Global albumin market revenue, 2015 – 2024 (USD Billion)
4. Porter’s five forces analysis
5. Albumin market attractiveness analysis, by product segment
6. Albumin market attractiveness analysis, by application segment
7. Albumin market attractiveness analysis, by end user segment
8. Albumin market: market attractiveness analysis, by regional segment
9. Company market share analysis, 2017
10. Global albumin market revenue share by product, 2017 and 2024
11. Global albumin market for human serum albumin, 2015 – 2024 (USD Billion)
12. Global albumin market for bovine serum albumin, 2015 – 2024 (USD Billion)
13. Global albumin market for recombinant albumin, 2015 – 2024 (USD Billion)
14. Global albumin market revenue share by application, 2017 and 2024
15. Global albumin market for drug delivery, 2015 – 2024 (USD Billion)
16. Global albumin market for vaccine ingredient, 2015 – 2024 (USD Billion)
17. Global albumin market for culture medium ingredient & stabilizer, 2015 – 2024 (USD Billion)
18. Global albumin market for in-vitro fertilization, 2015 – 2024 (USD Billion)
19. Global albumin market for others, 2015 – 2024 (USD Billion)
20. Global albumin market revenue share by end-user, 2017 and 2024
21. Global albumin market for pharmaceutical & biotechnology industry, 2015 – 2024 (USD Billion)
22. Global albumin market for research institutes, 2015 – 2024 (USD Billion)
23. Global albumin market for others, 2015 – 2024 (USD Billion)
24. North America albumin market, 2015-2024 (USD Billion)
25. Europe albumin market, 2015-2024 (USD Billion)
26. Asia Pacific albumin market, 2015-2024 (USD Billion)
27. Latin America albumin market, 2015-2024 (USD Billion)
28. The Middle East and Africa albumin market, 2015-2024 (USD Billion)


List of Tables

1. Global albumin market: Market Snapshot
2. Drivers of global albumin market: Impact analysis 
3. Restraints of global albumin market: Impact analysis
4. North America albumin market revenue, by product, 2015 – 2024 (USD Billion)
5. North America albumin market revenue, by application, 2015 – 2024 (USD Billion)
6. North America albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
7. The U.S. albumin market revenue, by product, 2015 – 2024 (USD Billion)
8. The U.S. albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
9. The U.S. albumin market revenue, by application, 2015 – 2024 (USD Billion)
10. Canada albumin market revenue, by product, 2015 – 2024 (USD Billion)
11. Canada albumin market revenue, by application, 2015 – 2024 (USD Billion)
12. Canada albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
13. Europe albumin market revenue, by product, 2015 – 2024 (USD Billion)
14. Europe albumin market revenue, by application, 2015 – 2024 (USD Billion)
15. Europe albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
16. UK albumin market revenue, by product, 2015 – 2024 (USD Billion)
17. UK albumin market revenue, by application, 2015 – 2024 (USD Billion)
18. UK albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
19. Germany albumin market revenue, by product, 2015 – 2024 (USD Billion)
20. Germany albumin market revenue, by application, 2015 – 2024 (USD Billion)
21. Germany albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
22. France albumin market revenue, by product, 2015 – 2024 (USD Billion)
23. France albumin market revenue, by application, 2015 – 2024 (USD Billion)
24. France albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
25. Rest of Europe albumin market revenue, by product, 2015 – 2024 (USD Billion)
26. Rest of Europe albumin market revenue, by application, 2015 – 2024 (USD Billion)
27. Rest of Europe albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
28. Asia Pacific albumin market revenue, by product, 2015 – 2024 (USD Billion)
29. Asia Pacific albumin market revenue, by application, 2015 – 2024 (USD Billion)
30. Asia Pacific albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
31. China albumin market revenue, by product, 2015 – 2024 (USD Billion)
32. China albumin market revenue, by application, 2015 – 2024 (USD Billion)
33. China albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
34. Japan albumin market revenue, by product, 2015 – 2024 (USD Billion)
35. Japan albumin market revenue, by application, 2015 – 2024 (USD Billion)
36. Japan albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
37. India albumin market revenue, by product, 2015 – 2024 (USD Billion)
38. India albumin market revenue, by application, 2015 – 2024 (USD Billion)
39. India albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
40. Rest of Asia Pacific albumin market revenue, by product, 2015 – 2024 (USD Billion)
41. Rest of Asia Pacific albumin market revenue, by application, 2015 – 2024 (USD Billion)
42. Rest of Asia Pacific albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
43. Latin America albumin market revenue, by product, 2015 – 2024 (USD Billion)
44. Latin America albumin market revenue, by application, 2015 – 2024 (USD Billion)
45. Latin America albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
46. Brazil albumin market revenue, by product, 2015 – 2024 (USD Billion)
47. Brazil albumin market revenue, by application, 2015 – 2024 (USD Billion)
48. Brazil albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
49. Rest of Latin America albumin market revenue, by product, 2015 – 2024 (USD Billion)
50. Rest of Latin America albumin market revenue, by application, 2015 – 2024 (USD Billion)
51. Rest of Latin America albumin market revenue, by end-user, 2015 – 2024 (USD Billion)
52. The Middle East & Africa albumin market revenue, by product, 2015 – 2024 (USD Billion)
53. The Middle East & Africa albumin market revenue, by application, 2015 – 2024 (USD Billion)
54. The Middle East & Africa albumin market revenue, by end-user, 2015 – 2024 (USD Billion)

Methodology

Free Analysis

Albumin is a type of protein found abundantly in the blood plasma. Albumin performs diverse kinds of functions, such as transporting fatty acids and hormones and maintaining the pressure. It also helps in restoring blood volume after surgeries, burns, infections, trauma, and in liver diseases and is used to replace lost fluid. It is also used in surface absorption and to stabilize drugs by lowering aggregation. Different kinds of serum albumin are extensively used in different clinical applications. 

In the Asia Pacific region, there are various awareness programs conducted by organizations, such as PPTA, to increase the awareness about plasma donation and the various plasma protein therapies available. The rising awareness and supportive activities by government and various organizations to increase awareness about the use of albumin are among the main factors fueling the growth of the global albumin market. The rise in applications of albumin in various fields, such as vaccines, media preparation, drug delivery, etc. is also fueling the growth of the global albumin market. The rise in the prevalence of diseases leading to hypoalbuminemia, increase in demand for albumin in non-therapeutic industry, the rise in demand for albumin in research and development, and rise in production of immunoglobin are some of the other factors driving the growth of the global albumin market.

Global Albumin Market

Albumin market can be categorized on the basis of application, product type, and end-user. On the basis of product type, the albumin market is segregated into recombinant albumin, bovine serum albumin, and human serum albumin. Human serum albumin segment is projected to lead the albumin market in the upcoming years. On the basis of application, the albumin market is segmented into therapeutics and diagnostics, drug delivery, vaccine ingredient, culture medium ingredient & stabilizer, in-vitro fertilization, and others. Drug delivery segment is anticipated to grow at a higher rate compared to other sub-segments. The end-user segment includes pharmaceutical & biotechnology industries, research institutes, and others. Pharmaceutical & biotechnology industries are expected to dominate the end-user segment of the global albumin market.

In terms of revenue share, Asia Pacific is expected to lead the albumin market in the upcoming years. Increase in the use of albumin for treatment of various diseases, increase in research and development activities, and increase in awareness about the therapeutic application of immunoglobin are some of the factors driving the albumin market in this region. North America is the second lucrative market for albumin, owing to the developed biotechnological industry, use of technologically developed procedures in R&D, and rise in the application of albumin in different clinical situations.

The main players in the global albumin market are Behring LLC, HiMedia Laboratories Pvt. Ltd., Albumedix A/S, Grifols International S.A., Albumin Therapeutics, LLC, InVitria, RayBiotech, Inc., Octapharma AG, Sigma-Aldrich Co., and SeraCare Life Sciences. The major companies focus on setting-up new manufacturing units to increase their production capacity. For instance, in September 2017, InVitria announced its expansion of laboratory facility to double its production capacity of recombinant proteins.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed